[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368874-105":59,"doc-detail-368874-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cd40lg-downregulation-in-lung-adenocarcinoma-a-prognostic-biomarker-linked-to-immune-cell-infiltration-and-survival-outcomes","CD40LG Downregulation in Lung Adenocarcinoma - A Prognostic Biomarker Linked to Immune Cell Infiltration and Survival Outcomes","","Lung adenocarcinoma (LUAD) remains difficult to treat, with limited survival benefits from immunotherapy, largely due to insufficient biomarkers and complex tumor immune microenvironments. This study evaluates CD40LG, an immune-related molecule implicated in immune regulation, to clarify its prognostic value and mechanistic links in LUAD. Prognostic correlation analyses across cancers, public datasets validation, clinical tissue validation, and immune-infiltration profiling via multiplex immunofluorescence support CD40LG’s functional association with patient outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cd40lg-downregulation-in-lung-adenocarcinoma-a-prognostic-biomarker-linked-to-immune-cell-infiltration-and-survival-outcomes/368874/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cd40lg-downregulation-in-lung-adenocarcinoma-a-prognostic-biomarker-linked-to-immune-cell-infiltration-and-survival-outcomes/368874.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in lung adenocarcinoma treatment?","Question",{"text":112,"@type":113},"It targets the challenge that LUAD has low survival rates and immunotherapy benefits are limited because effective biomarkers are lacking, likely influenced by the tumor immune microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CD40LG evaluated in this research?",{"text":117,"@type":113},"CD40LG significance was assessed using correlation analyses of prognosis and clinical traits across multiple cancers and confirmed with public datasets; protein expression was measured in LUAD tissues using immunohistochemistry, and immune infiltration was profiled using multiplex immunofluorescence.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationships did the study find between CD40LG expression and clinical outcomes?",{"text":121,"@type":113},"Higher CD40LG expression correlated with longer progression-free survival and overall survival, showed negative correlation with TNM and T stage, and was associated with increased infiltration of CD8+ T cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368874,1790198379,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Ivyspring  \nInternational Publisher  \nJournal of Cancer  \n2025; 16(13): 3884-3896. doi: 10.7150/jca.115525  \nResearch Paper  \nCD40LG Downregulation in Lung Adenocarcinoma: A Prognostic Biomarker Linked to Immune Cell Infiltration and Survival Outcomes  \nPeng Tang1*, Ruihao Zhang2,3*, Yuqi Zhang2*, Yuan Ao2, Yanan Wang2, Guannan Wang2, Wenjun Wang4, Junmei Xu4, Fang Hu2􀀍, Guangsheng Zhu1􀀍  \n1. Key Laboratory of Digestive Cancer of Tianjin, Tianjin’s Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.  \n2. Tianjin Medical University General Hospital, Tianjin 300052, People’s Republic of China.  \n3. Department of Thoracic Surgery, Shanghai Tongji Hospital, School of Medicine, Tongji University, Xincun Rd. 389, Shanghai, 200065, People's Republic of China.  \n4. Gomics Gene Technology Co. Ltd, Hangzhou, 310000, China.  \n*These authors contributed equally in this work.  \n􀀍 Corresponding authors: Guangsheng Zhu: [zhuguangsheng@tjmuch.com](zhuguangsheng@tjmuch.com); Fang Hu: [1430190119@qq.com](1430190119@qq.com)  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.04.10; Accepted: 2025.07.09; Published: 2025.08.22  \nAbstract  \nBackground: Lung adenocarcinoma (LUAD) continues to pose a major challenge in cancer treatment, characterized by low survival rates, particularly in metastatic instances. Although immunotherapy has become a common approach for treating LUAD, its success rate is merely 20%, hindered by the absence of effective biomarkers. This limitation is likely influenced by the tumor's immune microenvironment. CD40LG, an important immune molecule, has emerged as a crucial factor in modulating the tumor immune environment and affecting the outcomes of immunotherapy. Nevertheless, its exact mechanisms in LUAD remain unclear, requiring more research.  \nMethods: Through a correlation analysis of prognosis and clinical traits across multiple cancers, we determined that CD40LG is significant in LUAD. This role was confirmed using various public datasets. We evaluated CD40LG protein expression in 94 LUAD and nearby non-cancerous tissues via immunohistochemistry. To gauge immune cell infiltration, we employed multiplex immunofluorescence staining on tissue microarrays. Additionally, in vitro assays were carried out to explore the effects of CD40LG modulation on the behavior of LUAD cells.  \nResults: Various cancers, including LUAD, exhibited down-regulation of CD40LG, which correlated with a worse prognosis. In LUAD tissues, higher CD40LG expression was associated with longer Progression-Free Survival (PFS) and Overall Survival (OS). Moreover, CD40LG expression negatively correlated with the TNM stage and T stage in LUAD. Elevated CD40LG levels were linked to increased infiltration of CD8+ T cells. In vitro studies showed that modulating CD40LG affected LUAD cell metastasis and proliferation.  \nConclusion: Our study demonstrates the pivotal role of CD40LG in LUAD, proposing its potential utility as a biomarker for prognosis and immunotherapy. The correlation between CD40LG expression, immune cell infiltration, and clinical outcomes emphasizes its importance in tumor-immune dynamics and the efficacy of immunotherapy.  \nKeywords: CD40LG, Immune Microenvironment, LUAD, Biomarker, Immunotherapy Biomarkers.  \nIntroduction  \nWith approximately 1.8 million deaths related to lung cancer, and 2.1 million new cases diagnosed each  \nyear, lung cancer is one of the most prevalent malignant tumor in the world [1]. Approximately 15%  \nto 85% of cases of lung cancer fall into one of two primary categories: non-small-cell lung cancer (NSCLC) and small-cell lung cancer","cbCaiaPEVZIofMFA","https://ap.wps.com/l/cbCaiaPEVZIofMFA","pdf",5241527,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n# CD40LG and the Tumor Immune Microenvironment","[{\"question\":\"What problem does the study address in lung adenocarcinoma treatment?\",\"answer\":\"It targets the challenge that LUAD has low survival rates and immunotherapy benefits are limited because effective biomarkers are lacking, likely influenced by the tumor immune microenvironment.\"},{\"question\":\"How was CD40LG evaluated in this research?\",\"answer\":\"CD40LG significance was assessed using correlation analyses of prognosis and clinical traits across multiple cancers and confirmed with public datasets; protein expression was measured in LUAD tissues using immunohistochemistry, and immune infiltration was profiled using multiplex immunofluorescence.\"},{\"question\":\"What relationships did the study find between CD40LG expression and clinical outcomes?\",\"answer\":\"Higher CD40LG expression correlated with longer progression-free survival and overall survival, showed negative correlation with TNM and T stage, and was associated with increased infiltration of CD8+ T cells.\"}]","CD40LG Downregulation in Lung Adenocarcinoma - A Prognostic Biomarker Linked to Immune Cell Infiltration and Survival Outcomes | PDF",1790179022,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78994c3cc7e74401bf2263fa8a5e8f65.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f86485755a489f87a3aa8bc1ff73f00.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4e6aadae3d8578a9a11937b1f654cf6.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce56a274ca3e020c64f198ad9b70798a.webp",980,1268]